In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues | -66.4 | 88.6 | 61.7 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 |
Revenue growth | -174.9% | 43.6% | | | | | -100.0% | |
Cost of goods sold | 2.7 | 2.3 | 2.3 | 3.8 | 3.4 | 2.7 | 3.9 | 0.0 |
Gross profit | -69.1 | 86.3 | 59.5 | -3.8 | -3.4 | -2.7 | -3.9 | 2.0 |
Gross margin | 104.1% | 97.4% | 96.3% | | | | | 100.0% |
Selling, general and administrative [+] | 1.8 | 1.4 | 1.6 | 1.5 | 1.3 | 1.5 | 1.6 | 0.1 |
Sales and marketing | | | | 1.2 | 1.0 | 1.3 | 1.3 | |
General and administrative [+] | 1.8 | 1.4 | 1.6 | 0.3 | 0.3 | 0.3 | 0.4 | |
General and administrative expenses | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | | 0.0 |
Professional fees | 1.4 | 1.1 | 1.3 | | | | | |
Other selling, general and administrative | | | | 1.2 | 1.0 | 1.3 | 1.3 | |
Other operating expenses | 0.4 | 0.4 | 0.4 | 22.2 | 6.9 | 15.4 | -9.4 | |
EBIT [+] | -71.3 | 84.6 | 57.5 | -27.5 | -11.6 | -19.6 | 3.8 | 1.9 |
EBIT growth | -184.3% | 47.0% | | 136.5% | -40.7% | -612.2% | 101.0% | -66.6% |
EBIT margin | 107.4% | 95.4% | 93.2% | | | | | 93.7% |
Interest income | | | | 0.2 | 0.0 | 0.0 | 0.1 | |
Interest income | | | | 0.2 | 0.0 | 0.0 | 0.1 | |
Other income (expense), net [+] | -6.9 | -2.1 | -1.4 | | | | | -2.4 |
Gain (loss) on investments | | | | | | 0.0 | | |
Pre-tax income | -78.2 | 82.4 | 56.2 | -27.3 | -11.6 | -19.6 | 3.9 | -0.5 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -78.2 | 82.4 | 56.2 | -27.3 | -11.6 | -19.6 | 3.9 | -0.5 |
Net margin | 117.7% | 93.0% | 91.0% | | | | | -23.2% |
|
Basic EPS | | | | | | | | ($0.21) |
Diluted EPS | | | | | | | | ($0.21) |
|
Shares outstanding (basic) | | | | | | | | 2.2 |
Shares outstanding (diluted) | | | | | | | | 2.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |